C M Perou - JoVE Visualize

Showing results (31-40 of 46) with videos related to

Pageof 5

Sort By:

Breast Cancer Research and Treatment|February 8, 2008

Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) programW F Anderson, S Luo, N Chatterjee, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 13, 2001

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsT Sørlie, C M Perou, R Tibshirani, et al.

ESMO Open|April 19, 2023

Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysisF Schettini, O Martínez-Sáez, C Falato, et al.

ESMO Open|March 5, 2024

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network-Breast dataset (SCAN-B)G Villacampa, T Pascual, F Brasó-Maristany, et al.

Nature Genetics|March 4, 2000

Systematic variation in gene expression patterns in human cancer cell linesD T Ross, U Scherf, M B Eisen, et al.

Breast Cancer Research and Treatment|April 6, 2011

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancerM Martin, A Romero, M C U Cheang, et al.

BMC Genomics|June 5, 2019

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer seriesA C Picornell, I Echavarria, E Alvarez, et al.

Nature|August 30, 2000

Molecular portraits of human breast tumoursC M Perou, T Sørlie, M B Eisen, et al.

ESMO Open|January 18, 2025

HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancersF Lynce, O Martínez-Sáez, B Walbaum, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)A Fernandez-Martinez, M Tanioka, S G Ahn, et al.

Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:

Pageof 5

Breast Cancer Research and Treatment|February 8, 2008

Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) programW F Anderson, S Luo, N Chatterjee, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 13, 2001

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsT Sørlie, C M Perou, R Tibshirani, et al.

ESMO Open|April 19, 2023

Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysisF Schettini, O Martínez-Sáez, C Falato, et al.

ESMO Open|March 5, 2024

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network-Breast dataset (SCAN-B)G Villacampa, T Pascual, F Brasó-Maristany, et al.

Nature Genetics|March 4, 2000

Systematic variation in gene expression patterns in human cancer cell linesD T Ross, U Scherf, M B Eisen, et al.

Breast Cancer Research and Treatment|April 6, 2011

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancerM Martin, A Romero, M C U Cheang, et al.

BMC Genomics|June 5, 2019

Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer seriesA C Picornell, I Echavarria, E Alvarez, et al.

Nature|August 30, 2000

Molecular portraits of human breast tumoursC M Perou, T Sørlie, M B Eisen, et al.

ESMO Open|January 18, 2025

HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancersF Lynce, O Martínez-Sáez, B Walbaum, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2024

Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)A Fernandez-Martinez, M Tanioka, S G Ahn, et al.

Pageof 5